These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis. Righi E, Carnelutti A, Muser D, Di Gregorio F, Cadeo B, Melchioretto G, Merelli M, Alavi A, Bassetti M. Skeletal Radiol; 2020 Jun; 49(6):903-912. PubMed ID: 31900514 [Abstract] [Full Text] [Related]
23. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis. Bassetti M, Merelli M, Di Gregorio F, Della Siega P, Screm M, Scarparo C, Righi E. Skeletal Radiol; 2017 Jun; 46(6):777-783. PubMed ID: 28299432 [Abstract] [Full Text] [Related]
24. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery. Nakahara M, Ito M, Hattori N, Magota K, Takahata M, Nagahama K, Sudo H, Kamishima T, Tamaki N, Iwasaki N. Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515 [Abstract] [Full Text] [Related]
26. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH. Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481 [Abstract] [Full Text] [Related]
27. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia. Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS. Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667 [Abstract] [Full Text] [Related]
28. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer. García Vicente AM, Soriano Castrejón A, Cruz Mora MÁ, Ortega Ruiperez C, Espinosa Aunión R, León Martín A, González Ageitos A, Van Gómez López O. Rev Esp Med Nucl Imagen Mol; 2014 Jan; 33(1):1-5. PubMed ID: 23707190 [Abstract] [Full Text] [Related]
35. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited. Zhang X, Wu F, Han P. Hell J Nucl Med; 2014 Jul; 17(3):177-83. PubMed ID: 25526754 [Abstract] [Full Text] [Related]
36. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw. Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS. J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572 [Abstract] [Full Text] [Related]
37. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF. Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [Abstract] [Full Text] [Related]
38. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer. Zhang S, Li W, Liang F. Oncotarget; 2016 Jul 26; 7(30):48600-48606. PubMed ID: 27203206 [Abstract] [Full Text] [Related]
40. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan 26; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]